Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Satellos Bioscience Inc (MSCL.TO)

Satellos Bioscience Inc (MSCL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 205,916
  • Shares Outstanding, K 20,831
  • Annual Sales, $ 0 K
  • Annual Income, $ -24,873 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.47
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.34

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate $-0.05
  • Number of Estimates 1
  • High Estimate $-0.05
  • Low Estimate $-0.05
  • Prior Year $-0.06
  • Growth Rate Est. (year over year) +16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.67 +29.99%
on 04/07/26
11.58 -13.90%
on 03/19/26
-1.01 (-9.20%)
since 03/13/26
3-Month
7.67 +29.99%
on 04/07/26
18.98 -47.47%
on 03/03/26
-0.59 (-5.59%)
since 01/15/26
52-Week
6.24 +59.78%
on 06/17/25
18.98 -47.47%
on 03/03/26
+2.17 (+27.82%)
since 04/15/25

Most Recent Stories

More News
Satellos to Present at the Bloom Burton & Co. Healthcare Investor Conference

TORONTO, April 09, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL)  (“  Satellos  ” or the “  Company  ”), a clinical-stage biotechnology company developing...

MSLE : 7.25 (+1.12%)
MSCL.TO : 9.97 (+0.81%)
Stocks in play: Satellos Bioscience Inc.

Announced financial results and corporate highlights for the full year ended Dec. 31, 2025. For the ...

MSCL.TO : 9.97 (+0.81%)
Satellos Bioscience: Q4 Earnings Snapshot

Satellos Bioscience: Q4 Earnings Snapshot

MSCL.TO : 9.97 (+0.81%)
Satellos Reports 2025 Financial Results and Highlights Recent Company Progress

Completed a US$57.2 million equity financing; commenced trading on the Nasdaq Global Market under the ticker “MSLE” on Feb. 6, 2026 Secured global regulatory clearances and initiated BASECAMP,...

MSLE : 7.25 (+1.12%)
MSCL.TO : 9.97 (+0.81%)
Stocks in play: Satellos Bioscience Inc.

Today announced interim clinical and biomarker data for SAT-3247 at the Muscular Dystrophy Association ...

MSCL.TO : 9.97 (+0.81%)
Satellos Presents Interim SAT-3247 Clinical and Biomarker Data in Duchenne Muscular Dystrophy at the 2026 MDA Clinical & Scientific Conference

Interim observations from the Phase 2 TRAILHEAD study show continued improvement in handgrip strength, overall stability of elbow and shoulder strength in new dynamometry measurements Greater improvements...

MSLE : 7.25 (+1.12%)
MSCL.TO : 9.97 (+0.81%)
Stocks in play: Satellos Bioscience Inc.

Will present two oral scientific presentations and three posters at the 2026 Muscular Dystrophy Association ...

MSCL.TO : 9.97 (+0.81%)
Satellos Announces Upcoming Oral and Poster Presentations at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference

Satellos Bioscience Inc. (Nasdaq: MSLE, TSX: MSCL) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases,...

MSLE : 7.25 (+1.12%)
MSCL.TO : 9.97 (+0.81%)
Satellos to Host Virtual KOL Event on SAT-3247 in Duchenne Muscular Dystrophy

Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle...

MSLE : 7.25 (+1.12%)
MSCL.TO : 9.97 (+0.81%)
Satellos to Participate in Upcoming Investor Conferences

Satellos Bioscience Inc. (Nasdaq: MSLE , TSX: MSCL ) (“Satellos” or the “Company”), a clinical-stage biotechnology company focused on restoring natural muscle...

MSLE : 7.25 (+1.12%)
MSCL.TO : 9.97 (+0.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne...

See More

Key Turning Points

3rd Resistance Point 10.97
2nd Resistance Point 10.66
1st Resistance Point 10.28
Last Price 9.97
1st Support Level 9.59
2nd Support Level 9.28
3rd Support Level 8.90

See More

52-Week High 18.98
Fibonacci 61.8% 14.11
Fibonacci 50% 12.61
Fibonacci 38.2% 11.11
Last Price 9.97
52-Week Low 6.24

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.